MedPath

A randomized controlled study of improved pelvic sacral moxibustion in the prevention and treatment of primary dysmenorrhea with cold coagulation and blood stasis

Phase 1
Conditions
primary dysmenorrhea with cold coagulation and blood stasis
Registration Number
ITMCTR2200006074
Lead Sponsor
The Third Affiliated Hospital of Zhejiang Chinese Medical University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Female
Target Recruitment
Not specified
Inclusion Criteria

? Women aged between 18 and 50;
? Regular menstrual cycle (21±7 days);
? Color ultrasound and gynecological examination showed no organic disease;
? Dysmenorrhea VAS (visual analog score) >40 at the time of inclusion
? In the menstrual cycle prior to this treatment, no other treatment was received, and no analgesics, sedatives or hormone drugs were taken;
? Nearly half a year without pregnancy plan;
? The patients voluntarily participate and sign the informed consent.

Exclusion Criteria

? Breast-feeding women;
? Those who suffer from other serious systemic diseases, such as cardiovascular diseases and malignant tumors, and those who are considered unsuitable for the study by the researcher;
? Those who are currently undergoing other treatments (drug or non-drug), which may affect the measurement of effect indicators in this study;
? Do not cooperate with treatment plan arrangement;
? Fever or other factors resulting in abnormal body temperature;
? Superficial sensory disorders;
? People who are allergic to ginger or alcohol.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Severity of dysmenorrhea;
Secondary Outcome Measures
NameTimeMethod
infrared thermography;TCM symptoms and signs;Menstruation situation;Hemodynamic examination of endometrium and uterine artery;
© Copyright 2025. All Rights Reserved by MedPath